Mario Mendes Leitao, MD
Associate Member
Memorial Sloan Kettering Cancer Center
Dept. of Surgery
1275 York Ave.
New York,
NY
USA
10065
Biographical Sketch: I have been performing gynecologic surgeries with the robotic platform since 2006. Currently, I serve as Co-Director of the Robotic Surgery Program for the Department of Surgery at Memorial Sloan-Kettering Cancer Center. We have been using the robotic platform increasingly for more advanced gynecologic oncology procedures including splenectomy, bowel resections, and tumor cytoreduction. We have published our experience incorporating the platform and continue to analyze our experience."
Papers:
117 - Featured Poster
The feasibility and safety of same-day discharge after robotic-assisted hysterectomy alone or with other procedures for benign and malignant indications
119 - Featured Poster
Is robotic-assisted surgery safe in the elderly population? An analysis of gynecologic procedures in patients ≥65 years old
123 - Featured Poster
Maximizing minimally invasive surgical approaches in the morbidly obese patient with newly diagnosed uterine cancer
143 - Scientific Plenary
Prospective validation of pooled clinical prognostic factors in patients with recurrent and advanced cervical cancer: a Gynecologic Oncology Group (GOG) study
144 - Scientific Plenary
High-risk patients with recurrent/advanced cervical cancer may derive the most benefit from antiangiogenesis therapy: a Gynecologic Oncology Group (GOG) study
215 - Poster Session A
Incidence of lymph node metastasis in comprehensively staged clear cell carcinoma grossly confined to the ovary
254 - Poster Session A
An analysis of the survival outcomes of video-assisted thoracic surgery in the primary management of patients with advanced ovarian, tubal, and peritoneal cancer
323 - Poster Session A
Outcomes in node-positive low-grade endometrioid endometrial carcinoma
325 - Poster Session A
Nodal selection during side-specific lymphadenectomy in cases of failed sentinel node mapping
335 - Poster Session A
Combined modality adjuvant therapy for FIGO stage IIIC endometrial carcinomas
493 - Poster Session B
Does removal of a positive sentinel node without lymphadenectomy impact pelvic sidewall control in endometrial cancer?
498 - Poster Session B
Does minimally invasive surgery compromise the oncologic outcome of women with high-risk non-endometrioid endometrial carcinomas
Multitude any robotic surgery: concurrent splenectomy and pelvic mass resection
Robotics in Gynecologic Oncology
Hands On Lab: Robotics Proctors